Showing results (701-710 of 1,039) with videos related to
Sort By:
Pageof 104
The European Respiratory Journal|November 2, 2013
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposureKerri A Johannson, Eric Vittinghoff, Kiyoung Lee, et al.Journal of Crohn'S & Colitis|June 17, 2015
Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn's Disease: Impact on Clinical Decision MakingKerri Novak, Divine Tanyingoh, Frauke Petersen, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /betaC Manca, L Tsenova, A Bergtold, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2000
The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimeticN Fotouhi, P Joshi, D Fry, et al.Annals of Internal Medicine|April 15, 1996
Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1D M Thea, R Porat, K Nagimbi, et al.Breast Cancer Research and Treatment|March 25, 2024
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancerHenry G Kaplan, Alexa K Dowdell, Anna B Berry, et al.Vaccines|November 26, 2025
COVID-19 Vaccination, Hospitalization Rates, and Mortality Differ Between People with Diagnosed Immune Mediated Inflammatory Disease and the General Population: A Population-Based StudyCarol A Hitchon, Carole Taylor, Charles N Bernstein, et al.Journal of Virology|January 19, 2007
Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactionsCecilia Tami, Erica Silberstein, Mohanraj Manangeeswaran, et al.The Journal of Infectious Diseases|October 13, 2001
The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected childrenW A Hanekom, J Hughes, P A Haslett, et al.Inflammatory Bowel Diseases|November 24, 2015
Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized TrialJennifer deBruyn, Kevin Fonseca, Subrata Ghosh, et al.Pageof 104